| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |